Fig. 9From: Novel Pt@PCN-Cu-induced cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulationEnhanced cancer therapy by targeting cancer cells through Pt@PCN-Cu-induced cuproptosis combined with αPD-L1.Back to article page